Universal Health Realty me Trust(UHT)
Search documents
UNIVERSAL HEALTH REALTY INCOME TRUST REPORTS 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS
Prnewswire· 2025-02-26 21:40
Consolidated Results of Operations - Three-Month Periods Ended December 31, 2024 and 2023: KING OF PRUSSIA, Pa., Feb. 26, 2025 /PRNewswire/ -- Universal Health Realty Income Trust (NYSE:UHT) announced today that for the three-month period ended December 31, 2024, net income was $4.7 million, or $.34 per diluted share, as compared to $3.6 million, or $.26 per diluted share, during the fourth quarter of 2023. As reflected on the attached Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule"), ...
Universal Health Realty me Trust(UHT) - 2024 Q3 - Quarterly Results
2024-10-24 20:20
[Universal Health Realty Income Trust Q3 2024 Earnings Release](index=1&type=section&id=Universal%20Health%20Realty%20Income%20Trust%20Q3%202024%20Earnings%20Release) This report details Universal Health Realty Income Trust's financial and operational performance for Q3 and the first nine months of 2024 [Financial Performance](index=1&type=section&id=Financial%20Performance) The Trust achieved year-over-year growth in net income and FFO for Q3 and YTD 2024, driven by property income and expense reductions, despite higher interest costs [Third Quarter 2024 Results (Three-Month Period)](index=1&type=section&id=Consolidated%20Results%20of%20Operations%20-%20Three-Month%20Periods%20Ended%20September%2030%2C%202024%20and%202023%3A) The third quarter of 2024 saw increases in net income, diluted EPS, FFO, and FFO per diluted share compared to the prior year Q3 2024 vs. Q3 2023 Financial Highlights (Millions) | Metric | Q3 2024 (Millions) | Q3 2023 (Millions) | Change (Millions) | | :--- | :--- | :--- | :--- | | Net Income | $4.0 | $3.9 | +$0.1 | | Diluted EPS | $0.29 | $0.28 | +$0.01 | | FFO | $11.3 | $11.2 | +$0.1 | | FFO per Diluted Share | $0.82 | $0.81 | +$0.01 | - The increase in Q3 net income was primarily driven by a **$451,000** net increase in income from various properties, partially offset by a **$326,000** increase in interest expense[1](index=1&type=chunk) [Year-to-Date 2024 Results (Nine-Month Period)](index=1&type=section&id=Consolidated%20Results%20of%20Operations%20-%20Nine-Month%20Periods%20Ended%20September%2030%2C%202024%20and%202023%3A) The first nine months of 2024 demonstrated substantial growth in net income and FFO, driven by property income and reduced Chicago property expenses Nine Months 2024 vs. 2023 Financial Highlights (Millions) | Metric | Nine Months 2024 (Millions) | Nine Months 2023 (Millions) | Change (Millions) | | :--- | :--- | :--- | :--- | | Net Income | $14.6 | $11.8 | +$2.8 | | Diluted EPS | $1.05 | $0.85 | +$0.20 | | FFO | $36.1 | $33.2 | +$2.9 | | FFO per Diluted Share | $2.61 | $2.40 | +$0.21 | - The **$2.8 million** increase in nine-month net income resulted from a **$2.5 million** increase in income from various properties and a **$1.9 million** reduction in expenses related to the Chicago property, partially offset by a **$1.6 million** increase in interest expense[2](index=2&type=chunk)[3](index=3&type=chunk) [Shareholder Returns](index=2&type=section&id=Shareholder%20Returns) The Trust declared and paid a third-quarter dividend of **$0.73 per share**, reflecting an increase from the prior year - A third-quarter dividend of **$0.73 per share**, totaling **$10.1 million**, was declared on September 4, 2024, and paid on September 30, 2024[4](index=4&type=chunk) Dividend Per Share Comparison ($) | Period | Dividend per Share ($) | | :--- | :--- | | Q3 2024 | $0.730 | | Q3 2023 | $0.720 | | Nine Months 2024 | $2.185 | | Nine Months 2023 | $2.155 | [Capital Structure and Liquidity](index=2&type=section&id=Capital%20Structure%20and%20Liquidity) The Trust enhanced financial flexibility by upsizing its credit facility to **$425 million** and extending maturity to 2028, while also entering an **$85 million** interest rate swap to manage risk [Capital Resources](index=2&type=section&id=Capital%20Resources%20Information%3A) The company amended its credit agreement, increasing borrowing capacity to **$425 million** and extending maturity, with **$77.2 million** available as of September 30, 2024 - On September 30, 2024, the company amended its credit agreement, increasing borrowing capacity to **$425 million** (from **$375 million**) and extending the maturity date to September 30, 2028, with an option for two additional six-month extensions[5](index=5&type=chunk) - As of September 30, 2024, the Trust had **$347.8 million** of borrowings outstanding under its revolving credit agreement, with **$77.2 million** of available borrowing capacity[5](index=5&type=chunk) [Financial Instruments](index=2&type=section&id=Financial%20Instruments%3A) The Trust entered an **$85 million** interest rate swap agreement with a fixed rate of **3.2725%** to hedge cash flows through September 2028 - In October 2024, the Trust entered into an interest rate swap agreement on a notional amount of **$85 million** to hedge cash flows[8](index=8&type=chunk) - The swap has a fixed interest rate of **3.2725%**, is effective from October 2, 2024, to September 30, 2028, and replaced two expired agreements[8](index=8&type=chunk)[9](index=9&type=chunk) [Portfolio and Operational Updates](index=2&type=section&id=Portfolio%20and%20Operational%20Updates) The Trust completed Sierra Medical Plaza I construction, secured a **ten-year master lease** for **68%** of its space, and managed other asset dispositions and marketing efforts [Project Development (Sierra Medical Plaza I)](index=2&type=section&id=Sierra%20Medical%20Plaza%20I%3A) Construction of Sierra Medical Plaza I, an **86,000 sq. ft.** medical office building, is substantially complete, with **68%** leased under a **ten-year master lease** - Construction was substantially completed in March 2023 on Sierra Medical Plaza I, an **86,000 sq. ft.** medical office building (MOB) in Reno, Nevada[6](index=6&type=chunk) - A **ten-year** master flex lease commenced in March 2023, covering approximately **68%** of the MOB's rentable space at an initial minimum annual rent of **$1.3 million**[6](index=6&type=chunk) - The total estimated cost for the MOB is approximately **$35 million**, with about **$30 million** incurred as of September 30, 2024[6](index=6&type=chunk) [Asset Dispositions and Management](index=2&type=section&id=Vacant%20Land%2FSpecialty%20Facility%3A) Demolition of the Chicago specialty hospital is complete, a Corpus Christi facility was sold, and marketing continues for vacant properties in Chicago and Evansville - Demolition of the former specialty hospital in Chicago was completed in 2023 at an aggregate cost of approximately **$1.5 million**[7](index=7&type=chunk) - In December 2023, the vacant specialty facility in Corpus Christi, Texas was sold[7](index=7&type=chunk) - The Trust continues to market vacant properties located in Chicago, Illinois, and Evansville, Indiana[7](index=7&type=chunk) [Financial Statements](index=5&type=section&id=Financial%20Statements) The consolidated financial statements present the Trust's financial position and performance, including income statements, balance sheets, and FFO reconciliations [Consolidated Statements of Income](index=5&type=section&id=Universal%20Health%20Realty%20Income%20Trust%20Consolidated%20Statements%20of%20Income) The income statement summarizes total revenues, expenses, net income, and diluted EPS for Q3 and the nine-month periods of 2024 and 2023 Income Statement Summary (Thousands) | Account | Q3 2024 (Thousands) | Q3 2023 (Thousands) | Nine Months 2024 (Thousands) | Nine Months 2023 (Thousands) | | :--- | :--- | :--- | :--- | :--- | | Total Revenues | $24,494 | $24,223 | $74,369 | $71,255 | | Total Expenses | $20,497 | $20,351 | $60,254 | $59,448 | | Net Income | $3,997 | $3,872 | $14,573 | $11,807 | | Diluted EPS | $0.29 | $0.28 | $1.05 | $0.85 | [Consolidated Balance Sheets](index=8&type=section&id=Universal%20Health%20Realty%20Income%20Trust%20Consolidated%20Balance%20Sheets) The balance sheet provides a snapshot of the Trust's financial position, detailing assets, liabilities, and equity as of September 30, 2024 Balance Sheet Summary (Thousands) | Account | Sep 30, 2024 (Thousands) | Dec 31, 2023 (Thousands) | | :--- | :--- | :--- | | Net Real Estate Investments | $430,165 | $443,795 | | Total Assets | $584,330 | $596,369 | | Line of credit borrowings | $347,750 | $326,600 | | Total Liabilities | $402,691 | $395,435 | | Total Equity | $181,639 | $200,934 | [Non-GAAP Reconciliations (FFO)](index=6&type=section&id=Schedule%20of%20Non-GAAP%20Supplemental%20Information) This section provides reconciliations of net income to Funds From Operations (FFO) for both the third quarter and nine-month periods Q3 FFO Reconciliation (Thousands) | Account | Q3 2024 (Thousands) | Q3 2023 (Thousands) | | :--- | :--- | :--- | | Net Income | $3,997 | $3,872 | | Plus: Depreciation & Amortization | $7,320 | $7,321 | | **FFO** | **$11,317** | **$11,193** | Nine Months FFO Reconciliation (Thousands) | Account | Nine Months 2024 (Thousands) | Nine Months 2023 (Thousands) | | :--- | :--- | :--- | | Net Income | $14,573 | $11,807 | | Plus: Depreciation & Amortization | $21,542 | $21,379 | | **FFO** | **$36,115** | **$33,186** | [Disclosures](index=3&type=section&id=General%20Information%2C%20Forward-Looking%20Statements%20and%20Risk%20Factors%20and%20Non-GAAP%20Financial%20Measures%3A) This section provides an overview of the Trust's operations as a REIT, outlines forward-looking statement disclaimers and associated risks, and explains the use of non-GAAP financial measures [About the Company](index=3&type=section&id=About%20the%20Company) Universal Health Realty Income Trust operates as a REIT, investing in **76 healthcare facilities** across **21 states** - Universal Health Realty Income Trust is a REIT that invests in **seventy-six properties** located in **twenty-one states**, including acute care hospitals, behavioral health hospitals, specialty facilities, and medical office buildings[9](index=9&type=chunk) [Forward-Looking Statements and Risk Factors](index=3&type=section&id=Forward-Looking%20Statements%20and%20Risk%20Factors) The press release contains forward-looking statements, warning that future results could be materially impacted by various operational and market risks - The press release contains forward-looking statements and warns that future results could be materially impacted by various factors, including staffing shortages, wage expense increases for tenants, government regulation of the healthcare industry, declining patient volumes, unfavorable payer mix from macroeconomic conditions, and increased borrowing costs due to rising interest rates[9](index=9&type=chunk) [Non-GAAP Financial Measures](index=3&type=section&id=Non-GAAP%20Financial%20Measures) The company utilizes non-GAAP financial measures, such as Funds from Operations (FFO), to provide investors with additional insights into operating performance - The company uses non-GAAP financial measures such as Funds from Operations (FFO) and adjusted net income, which it believes are helpful to investors for measuring operating performance[9](index=9&type=chunk) - FFO is computed in accordance with standards from the National Association of Real Estate Investment Trusts (NAREIT) and is not an alternative to net income or cash flow from operations under GAAP[9](index=9&type=chunk)[10](index=10&type=chunk)
UNIVERSAL HEALTH REALTY INCOME TRUST REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS
Prnewswire· 2024-10-24 20:15
Consolidated Results of Operations - Three-Month Periods Ended September 30, 2024 and 2023:KING OF PRUSSIA, Pa., Oct. 24, 2024 /PRNewswire/ -- Universal Health Realty Income Trust (NYSE:UHT) announced today that for the three-month period ended September 30, 2024, net income was $4.0 million, or $.29 per diluted share, as compared to $3.9 million, or $.28 per diluted share, during the third quarter of 2023.The increase in our net income of $125,000, or $.01 per diluted share, during the three-month period e ...
UNIVERSAL HEALTH REALTY INCOME TRUST ANNOUNCES DIVIDEND
Prnewswire· 2024-09-04 20:15
KING OF PRUSSIA, Pa., Sept. 4, 2024 /PRNewswire/ -- Universal Health Realty Income Trust (NYSE:UHT) announced today that its Board of Trustees voted to pay a dividend of $.73 per share on September 30, 2024 to shareholders of record as of September 16, 2024. Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human servicerelated facilities including acute care hospitals, behavioral healthcare facilities, rehabilitation hospitals, subacute care facilities, surgery ...
Universal Health Realty me Trust(UHT) - 2024 Q2 - Quarterly Results
2024-07-24 20:25
[Executive Summary](index=1&type=section&id=Executive%20Summary) Universal Health Realty Income Trust achieved significant Q2 2024 financial improvements, with net income up $1.8 million to $5.3 million and FFO increasing by $1.8 million to $12.4 million [2024 Second Quarter Financial Highlights](index=1&type=section&id=2024%20Second%20Quarter%20Financial%20Highlights) The company reported strong Q2 2024 financial performance, with net income rising to $5.3 million and FFO increasing to $12.4 million 2024 Second Quarter Financial Highlights | Metric | Q2 2024 | Q2 2023 | Change | | :------------------- | :------ | :------ | :----- | | Net Income | $5.3M | $3.5M | +$1.8M | | Diluted EPS | $0.38 | $0.25 | +$0.13 | | FFO | $12.4M | $10.6M | +$1.8M | | Diluted FFO per Share | $0.90 | $0.77 | +$0.13 | [Consolidated Results of Operations](index=1&type=section&id=Consolidated%20Results%20of%20Operations) This section details the company's financial performance for the three and six-month periods ended June 30, 2024 and 2023 [Three-Month Periods Ended June 30, 2024 and 2023](index=1&type=section&id=Consolidated%20Results%20of%20Operations%20-%20Three-Month%20Periods%20Ended%20June%2030%2C%202024%20and%202023) For the second quarter of 2024, the company experienced a substantial increase in net income and FFO, driven by reduced Chicago property expenses and increased property income [Net Income Analysis](index=1&type=section&id=Net%20Income%20Analysis%20-%20Three%20Months) This analysis details the drivers behind the increase in net income for the three-month period ended June 30, 2024 Net Income and EPS (Three Months Ended June 30) | Metric | Q2 2024 | Q2 2023 | Change | | :------------------- | :------ | :------ | :----- | | Net Income | $5.276M | $3.476M | +$1.8M | | Diluted EPS | $0.38 | $0.25 | +$0.13 | - **Drivers of Net Income Increase (Q2 2024 vs. Q2 2023):** * Reduction in Chicago property expenses: **$1.5 million**, including **$862,000** from demolition expenses incurred in Q2 2023 and **$563,000** from a property tax reduction recorded in Q2 2024 primarily related to prior periods[3](index=3&type=chunk) * Aggregate net increase in income generated at various properties: **$706,000**[3](index=3&type=chunk) * Partially offset by an increase in interest expense: **$404,000**, due primarily to increases in average borrowing rate and outstanding borrowings[3](index=3&type=chunk) [Funds From Operations (FFO) Analysis](index=1&type=section&id=Funds%20From%20Operations%20%28FFO%29%20Analysis%20-%20Three%20Months) This analysis focuses on the factors contributing to the increase in FFO for the three-month period ended June 30, 2024 FFO and FFO per Diluted Share (Three Months Ended June 30) | Metric | Q2 2024 | Q2 2023 | Change | | :------------------- | :------ | :------ | :----- | | FFO | $12.4M | $10.6M | +$1.8M | | Diluted FFO per Share | $0.90 | $0.77 | +$0.13 | - **Driver of FFO Increase (Q2 2024 vs. Q2 2023):** * Primarily due to the above-mentioned increase in net income[4](index=4&type=chunk) [Six-Month Periods Ended June 30, 2024 and 2023](index=1&type=section&id=Consolidated%20Results%20of%20Operations%20-%20Six-Month%20Periods%20Ended%20June%2030%2C%202024%20and%202023) For the first six months of 2024, the company reported a solid increase in net income and FFO, driven by increased property income and reduced Chicago property expenses [Net Income Analysis](index=1&type=section&id=Net%20Income%20Analysis%20-%20Six%20Months) This analysis details the drivers behind the increase in net income for the six-month period ended June 30, 2024 Net Income and EPS (Six Months Ended June 30) | Metric | H1 2024 | H1 2023 | Change | | :------------------- | :------ | :------ | :----- | | Net Income | $10.6M | $7.9M | +$2.6M | | Diluted EPS | $0.76 | $0.57 | +$0.19 | - **Drivers of Net Income Increase (H1 2024 vs. H1 2023):** * Aggregate net increase in income generated at various properties: **$2.1 million**[6](index=6&type=chunk)[7](index=7&type=chunk) * Reduction in Chicago property expenses: **$1.8 million**, including **$1.1 million** from demolition expenses incurred in H1 2023 and **$563,000** from a property tax reduction recorded in H1 2024 primarily related to prior periods[6](index=6&type=chunk)[7](index=7&type=chunk) * Partially offset by an increase in interest expense: **$1.3 million**, due primarily to increases in average borrowing rate and outstanding borrowings[6](index=6&type=chunk)[7](index=7&type=chunk) [Funds From Operations (FFO) Analysis](index=2&type=section&id=Funds%20From%20Operations%20%28FFO%29%20Analysis%20-%20Six%20Months) This analysis focuses on the factors contributing to the increase in FFO for the six-month period ended June 30, 2024 FFO and FFO per Diluted Share (Six Months Ended June 30) | Metric | H1 2024 | H1 2023 | Change | | :------------------- | :------ | :------ | :----- | | FFO | $24.8M | $22.0M | +$2.8M | | Diluted FFO per Share | $1.79 | $1.59 | +$0.20 | - **Drivers of FFO Increase (H1 2024 vs. H1 2023):** * Primarily due to the above-mentioned increase in net income[8](index=8&type=chunk) * Increase in depreciation and amortization expense[8](index=8&type=chunk) [Key Financial and Operational Updates](index=2&type=section&id=Key%20Financial%20and%20Operational%20Updates) This section provides essential updates on the company's dividends, capital resources, and property portfolio developments [Dividend Information](index=2&type=section&id=Dividend%20Information) The company declared and paid a second-quarter dividend of $0.73 per share, totaling $10.1 million Q2 2024 Dividend | Metric | Value | | :---------------- | :------ | | Dividend per Share | $0.73 | | Aggregate Dividend | $10.1M | | Declaration Date | June 5, 2024 | | Payment Date | June 28, 2024 | [Capital Resources Information](index=2&type=section&id=Capital%20Resources%20Information) As of June 30, 2024, the company had $342.9 million in outstanding borrowings against its $375 million revolving credit agreement, leaving $32.1 million in available borrowing capacity Borrowing Capacity (as of June 30, 2024) | Metric | Value | | :-------------------------------- | :-------- | | Revolving Credit Agreement Limit | $375M | | Borrowings Outstanding | $342.9M | | Available Borrowing Capacity (net) | $32.1M | [Property Updates](index=2&type=section&id=Property%20Updates) The company provided updates on its property portfolio, including the substantial completion and leasing of Sierra Medical Plaza I and the status of its vacant properties in Chicago and Corpus Christi [Sierra Medical Plaza I](index=2&type=section&id=Sierra%20Medical%20Plaza%20I) This section details the construction, leasing, and aggregate cost of the Sierra Medical Plaza I development - **Construction and Lease Details:** * Construction was substantially completed in March 2023 for an 86,000 square foot Medical Office Building (MOB) in Reno, Nevada[11](index=11&type=chunk) * A master flex lease agreement commenced in March 2023 with a ten-year term, covering approximately **68%** of the rentable square feet at an initial minimum rent of **$1.3 million** annually, plus common area maintenance expenses, subject to reduction based on third-party leases[11](index=11&type=chunk) Aggregate Cost of Sierra Medical Plaza I | Metric | Value | | :---------------- | :------ | | Estimated Total Cost | ~$35M | | Incurred as of June 30, 2024 | ~$30M | [Vacant Land/Specialty Facility](index=2&type=section&id=Vacant%20Land%2FSpecialty%20Facility) This section provides updates on the demolition of the Chicago facility, the sale of the Corpus Christi facility, and future operating expenses for vacant properties - **Demolition and Sale Status:** * Demolition of the former specialty hospital in Chicago, Illinois, was completed during 2023, with aggregate demolition expenses of approximately **$1.5 million**[12](index=12&type=chunk) * The vacant specialty facility in Corpus Christi, Texas, was sold in December 2023[12](index=12&type=chunk) - **Future Operating Expenses:** * The company continues to market vacant properties in Chicago, Illinois, and Evansville, Indiana, and will incur future operating expenses for these properties until they are owned and unleased[13](index=13&type=chunk) [Company Overview and Disclosures](index=2&type=section&id=Company%20Overview%20and%20Disclosures) This section provides general company information, forward-looking statements, risk factors, and details on non-GAAP financial measures [General Information](index=2&type=section&id=General%20Information) Universal Health Realty Income Trust is a real estate investment trust (REIT) specializing in healthcare and human-service related facilities, with investments in 76 properties across 21 states - **Company Profile:** * Universal Health Realty Income Trust is a real estate investment trust (REIT)[14](index=14&type=chunk) * Invests in healthcare and human-service related facilities, including acute care hospitals, behavioral health care hospitals, specialty facilities, medical/office buildings, free-standing emergency departments, and childcare centers[14](index=14&type=chunk) * Has investments or commitments in seventy-six properties located in twenty-one states[14](index=14&type=chunk) [Forward-Looking Statements and Risk Factors](index=2&type=section&id=Forward-Looking%20Statements%20and%20Risk%20Factors) The report contains forward-looking statements subject to various risks, including staffing shortages, regulatory changes, declining patient volumes due to macroeconomic conditions, supply disruptions, and increased interest rates, which could materially impact future financial results - **Forward-Looking Statements Disclaimer:** * This press release contains forward-looking statements based on current management expectations[15](index=15&type=chunk)[16](index=16&type=chunk) * Numerous factors, including those disclosed in SEC filings (Form 10-K, Form 10-Q), may cause actual results to differ materially from those anticipated[15](index=15&type=chunk)[16](index=16&type=chunk) * Readers should not place undue reliance on such statements, which reflect management's view only as of the date hereof, and the company undertakes no obligation to revise or update them[15](index=15&type=chunk)[16](index=16&type=chunk) - **Key Risk Factors:** * **Staffing Availability & Wage Expense:** Decreases in staffing and related increases to wage expense experienced by tenants due to nationwide shortages of nurses and other clinical/support staff[17](index=17&type=chunk)[18](index=18&type=chunk) * **Government & Administrative Regulation:** Impact of government and administrative regulation of the health care industry[17](index=17&type=chunk)[18](index=18&type=chunk) * **Macroeconomic Conditions:** Declining patient volumes and unfavorable changes in payer mix caused by deteriorating macroeconomic conditions (e.g., increases in uninsured/underinsured patients)[17](index=17&type=chunk)[18](index=18&type=chunk) * **Supply Disruptions:** Potential disruptions related to supplies required for tenants' employees and patients[17](index=17&type=chunk)[18](index=18&type=chunk) * **Interest Rate Increases:** Substantially increased borrowing costs and reduced ability to access capital markets on favorable terms; additional increases could have a significant unfavorable impact on future results and strategy[17](index=17&type=chunk)[18](index=18&type=chunk) [Non-GAAP Financial Measures](index=3&type=section&id=Non-GAAP%20Financial%20Measures) The company utilizes non-GAAP financial measures like Adjusted Net Income and Funds From Operations (FFO) to provide investors with insights into operating performance, emphasizing that these measures are not substitutes for GAAP results and should be considered with caution - **Purpose of Non-GAAP Measures:** * Adjusted net income and adjusted net income per diluted share are considered helpful to investors as measures of operating performance[19](index=19&type=chunk) * These measures help neutralize the effect of material non-recurring or non-operational items[19](index=19&type=chunk) - **FFO Definition and Limitations:** * Funds from operations (FFO) is a widely recognized measure for Real Estate Investment Trusts (REITs), computed in accordance with NAREIT standards[20](index=20&type=chunk)[21](index=21&type=chunk)[22](index=22&type=chunk) * **Limitations:** FFO does not represent cash generated from operating activities in accordance with GAAP and should not be considered an alternative to net income, cash flow from operating activities, a measure of liquidity, or an indicator of funds available for cash needs (including distributions)[20](index=20&type=chunk)[21](index=21&type=chunk)[22](index=22&type=chunk) * Investors are encouraged to use GAAP measures when evaluating financial performance, as non-GAAP measures are susceptible to varying calculations and may not be comparable to other similarly titled measures of other companies[20](index=20&type=chunk)[21](index=21&type=chunk)[22](index=22&type=chunk) [Financial Statements](index=5&type=section&id=Financial%20Statements) This section presents the company's consolidated financial statements, including income statements, balance sheets, and non-GAAP reconciliations [Consolidated Statements of Income](index=5&type=section&id=Consolidated%20Statements%20of%20Income) This section presents the detailed consolidated income statements for the three and six months ended June 30, 2024 and 2023, outlining revenues, expenses, and net income Consolidated Statements of Income (For the Three and Six Months Ended June 30, 2024 and 2023) | | Three Months Ended | | | Six Months Ended | | | :------------------------------------------------- | :--- | :--- | :--- | :--- | :--- | | | June 30, 2024 | June 30, 2023 | June 30, 2024 | June 30, 2023 | | **Revenues:** | | | | | | Lease revenue - UHS facilities | $ 8,454 | $ 8,236 | $ 17,118 | $ 16,023 | | Lease revenue - Non-related parties | 14,359 | 13,668 | 28,846 | 27,029 | | Other revenue - UHS facilities | 220 | 245 | 440 | 476 | | Other revenue - Non-related parties | 342 | 292 | 751 | 773 | | Interest income on financing leases - UHS facilities | 1,359 | 1,365 | 2,720 | 2,731 | | **Total Revenues** | **24,734** | **23,806** | **49,875** | **47,032** | | **Expenses:** | | | | | | Depreciation and amortization | 6,806 | 6,849 | 13,615 | 13,467 | | Advisory fees to UHS | 1,369 | 1,323 | 2,707 | 2,625 | | Other operating expenses | 6,975 | 8,250 | 14,506 | 15,771 | | **Total Expenses** | **15,150** | **16,422** | **30,828** | **31,863** | | Income before equity in income of unconsolidated LLCs and interest expense | 9,584 | 7,384 | 19,047 | 15,169 | | Equity in income of unconsolidated LLCs | 272 | 268 | 656 | 639 | | Interest expense, net | (4,580) | (4,176) | (9,127) | (7,873) | | **Net income** | **$ 5,276** | **$ 3,476** | **$ 10,576** | **$ 7,935** | | Basic earnings per share | $ 0.38 | $ 0.25 | $ 0.77 | $ 0.58 | | Diluted earnings per share | $ 0.38 | $ 0.25 | $ 0.76 | $ 0.57 | | Weighted average number of shares outstanding - Diluted | 13,832 | 13,809 | 13,828 | 13,806 | [Schedule of Non-GAAP Supplemental Information - Three Months](index=6&type=section&id=Schedule%20of%20Non-GAAP%20Supplemental%20Information%20-%20Three%20Months) This schedule provides the reconciliation of net income to Adjusted Net Income and Funds From Operations (FFO) for the three-month periods ended June 30, 2024 and 2023, in accordance with NAREIT standards Calculation of Adjusted Net Income (Three Months Ended June 30) | | June 30, 2024 | | | June 30, 2023 | | | :------------------------ | :--- | :--- | :--- | :--- | :--- | | | Amount | Per Diluted Share | Amount | Per Diluted Share | | Net income | $ 5,276 | $ 0.38 | $ 3,476 | $ 0.25 | | Adjustments | - | - | - | - | | Subtotal adjustments to net income | - | - | - | - | | Adjusted net income | $ 5,276 | $ 0.38 | $ 3,476 | $ 0.25 | Calculation of Funds From Operations ("FFO") (Three Months Ended June 30) | | June 30, 2024 | | | June 30, 2023 | | | :------------------------------------ | :--- | :--- | :--- | :--- | :--- | | | Amount | Per Diluted Share | Amount | Per Diluted Share | | Net income | $ 5,276 | $ 0.38 | $ 3,476 | $ 0.25 | | Plus: Depreciation and amortization expense: | | | | | | Consolidated investments | 6,806 | 0.50 | 6,849 | 0.50 | | Unconsolidated affiliates | 303 | 0.02 | 298 | 0.02 | | FFO | $ 12,385 | $ 0.90 | $ 10,623 | $ 0.77 | | Dividend paid per share | | $ 0.730 | | $ 0.720 | [Schedule of Non-GAAP Supplemental Information - Six Months](index=7&type=section&id=Schedule%20of%20Non-GAAP%20Supplemental%20Information%20-%20Six%20Months) This schedule details the reconciliation of net income to Adjusted Net Income and Funds From Operations (FFO) for the six-month periods ended June 30, 2024 and 2023, adhering to NAREIT guidelines Calculation of Adjusted Net Income (Six Months Ended June 30) | | June 30, 2024 | | | June 30, 2023 | | | :------------------------ | :--- | :--- | :--- | :--- | :--- | | | Amount | Per Diluted Share | Amount | Per Diluted Share | | Net income | $ 10,576 | $ 0.76 | $ 7,935 | $ 0.57 | | Adjustments | - | - | - | - | | Subtotal adjustments to net income | - | - | - | - | | Adjusted net income | $ 10,576 | $ 0.76 | $ 7,935 | $ 0.57 | Calculation of Funds From Operations ("FFO") (Six Months Ended June 30) | | June 30, 2024 | | | June 30, 2023 | | | :------------------------------------ | :--- | :--- | :--- | :--- | :--- | | | Amount | Per Diluted Share | Amount | Per Diluted Share | | Net income | $ 10,576 | $ 0.76 | $ 7,935 | $ 0.57 | | Plus: Depreciation and amortization expense: | | | | | | Consolidated investments | 13,615 | 0.99 | 13,467 | 0.98 | | Unconsolidated affiliates | 607 | 0.04 | 591 | 0.04 | | FFO | $ 24,798 | $ 1.79 | $ 21,993 | $ 1.59 | | Dividend paid per share | | $ 1.455 | | $ 1.435 | [Consolidated Balance Sheets](index=8&type=section&id=Consolidated%20Balance%20Sheets) This section presents the consolidated balance sheets as of June 30, 2024, and December 31, 2023, providing a snapshot of the company's assets, liabilities, and equity Consolidated Balance Sheets (As of June 30, 2024 and December 31, 2023) | | June 30, 2024 | December 31, 2023 | | :-------------------------------------------------------------------------------- | :--- | :--- | | **Assets:** | | | | Real Estate Investments: | | | | Buildings and improvements and construction in progress | $ 651,638 | $ 649,374 | | Accumulated depreciation | (274,622) | (262,449) | | Net Real Estate Investments (subtotal) | 377,016 | 386,925 | | Land | 56,870 | 56,870 | | **Net Real Estate Investments** | **433,886** | **443,795** | | Financing receivable from UHS | 83,043 | 83,279 | | **Net Real Estate Investments and Financing receivable** | **516,929** | **527,074** | | Investments in limited liability companies ("LLCs") | 14,328 | 9,102 | | Other Assets: | | | | Cash and cash equivalents | 5,577 | 8,212 | | Lease and other receivables from UHS | 6,816 | 6,180 | | Lease receivable - other | 7,905 | 8,166 | | Intangible assets (net) | 8,193 | 9,110 | | Right-of-use land assets, net | 10,932 | 10,946 | | Deferred charges, notes receivable and other assets, net | 15,871 | 17,579 | | **Total Assets** | **$ 586,551** | **$ 596,369** | | **Liabilities:** | | | | Line of credit borrowings | $ 342,900 | $ 326,600 | | Mortgage notes payable, non-recourse to us, net | 19,970 | 32,863 | | Accrued interest | 1,024 | 490 | | Accrued expenses and other liabilities | 10,145 | 13,500 | | Ground lease liabilities, net | 10,932 | 10,946 | | Tenant reserves, deposits and deferred and prepaid rents | 10,879 | 11,036 | | **Total Liabilities** | **395,850** | **395,435** | | **Equity:** | | | | Common shares | 138 | 138 | | Capital in excess of par value | 270,592 | 270,398 | | Cumulative net income | 836,637 | 826,061 | | Cumulative dividends | (923,107) | (902,975) | | Accumulated other comprehensive income | 6,441 | 7,312 | | **Total Equity** | **190,701** | **200,934** | | **Total Liabilities and Equity** | **$ 586,551** | **$ 596,369** |
UNIVERSAL HEALTH REALTY INCOME TRUST REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS
Prnewswire· 2024-07-24 20:15
The increase in our net income of $1.8 million, or $.13 per diluted share, during the second quarter of 2024, as compared to the comparable quarter of 2023, consisted of the following: (i) an increase of $1.5 million, or $.11 per diluted share, resulting from a reduction in the expenses related to our property located in Chicago, Illinois, including $862,000 from demolition expenses incurred during the second quarter of 2023, and $563,000 related to a property tax reduction recorded during the second quarte ...
UNIVERSAL HEALTH REALTY INCOME TRUST ANNOUNCES DIVIDEND INCREASE
Prnewswire· 2024-06-05 20:15
Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human service- related facilities including acute care hospitals, behavioral healthcare facilities, rehabilitation hospitals, sub- acute care facilities, surgery centers, childcare centers, and medical office buildings. The Trust has seventy-six investments in twenty-one states. SOURCE Universal Health Realty Income Trust KING OF PRUSSIA, Pa., June 5, 2024 /PRNewswire/ -- Universal Health Realty Income Trust (NYS ...
Universal Health Realty me Trust(UHT) - 2024 Q1 - Quarterly Report
2024-05-08 20:20
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-9321 UNIVERSAL HEALTH REALTY INCOME TRUST (Exact name of registrant as specified in its charter) MARYLAND 23-6858580 (State or oth ...
Universal Health Realty me Trust(UHT) - 2024 Q1 - Quarterly Results
2024-04-24 20:20
Exhibit 99.1 UNIVERSAL HEALTH REALTY INCOME TRUST Universal Corporate Center 367 S. Gulph Road P.O. Box 61558 King of Prussia, PA 19406 (610) 265-0688 FOR IMMEDIATE RELEASE CONTACT: Charles Boyle April 24, 2024 Chief Financial Officer (610) 768-3300 The first quarter dividend of $.725 per share, or $10.0 million in the aggregate, was declared on March 6, 2024 and paid on March 29, 2024. Capital Resources Information: At March 31, 2024, we had $333.7 million of borrowings outstanding pursuant to the terms of ...
Universal Health Realty me Trust(UHT) - 2023 Q4 - Annual Results
2024-02-27 21:25
Exhibit 99.1 UNIVERSAL HEALTH REALTY INCOME TRUST Universal Corporate Center 367 S. Gulph Road P.O. Box 61558 King of Prussia, PA 19406 (610) 265-0688 FOR IMMEDIATE RELEASE CONTACT: Charles Boyle February 27, 2024 Chief Financial Officer (610) 768-3300 UNIVERSAL HEALTH REALTY INCOME TRUST REPORTS 2023 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS Consolidated Results of Operations - Three-Month Periods Ended December 31, 2023 and 2022: KING OF PRUSSIA, PA - Universal Health Realty Income Trust (NYSE:UHT) a ...